APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Herpes Treatment Industry Growth and Trends Forecast to 2032

22 December 202592 pages

Choose your research edition.

Industry ResearchHerpes Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Treatment Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Herpes Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Herpes Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Treatment include Abbott, Teva Pharmaceutical Industries, Novartis, Merck, Mylan, GlaxoSmithKline, Vical and Gilead, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Herpes Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Herpes Treatment market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Herpes Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Herpes Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Herpes Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Herpes Treatment Market by Company

Abbott

Teva Pharmaceutical Industries

Novartis

Merck

Mylan

GlaxoSmithKline

Vical

Gilead

Herpes Treatment Segment by Type

Famciclovir

Valacyclovir

Acyclovir

Herpes Treatment Segment by Application

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Drug Stores

Herpes Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herpes Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Herpes Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Famciclovir Table 2. Major Company of Valacyclovir Table 3. Major Company of Acyclovir Table 4. Global Herpes Treatment Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Herpes Treatment Sales by Type (2021-2026) & (k units) Table 6. Global Herpes Treatment Sales Market Share in Volume by Type (2021-2026) Table 7. Global Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 8. Global Herpes Treatment Sales Market Share in Value by Type (2021-2026) Table 9. Global Herpes Treatment Price by Type (2021-2026) & (US$/unit) Table 10. Global Herpes Treatment Sales by Type (2027-2032) & (k units) Table 11. Global Herpes Treatment Sales Market Share in Volume by Type (2027-2032) Table 12. Global Herpes Treatment Sales by Type (2027-2032) & (US$ Million) Table 13. Global Herpes Treatment Sales Market Share in Value by Type (2027-2032) Table 14. Global Herpes Treatment Price by Type (2027-2032) & (US$/unit) Table 15. North America Herpes Treatment Sales by Type (2021-2026) & (k units) Table 16. North America Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Herpes Treatment Sales by Type (2021-2026) & (k units) Table 18. Europe Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Herpes Treatment Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Herpes Treatment Sales by Type (2021-2026) & (k units) Table 22. Latin America Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Herpes Treatment Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Herpes Treatment Sales by Type (2021-2026) & (US$ Million) Table 25. Herpes Treatment Industry Trends Table 26. Herpes Treatment Industry Drivers Table 27. Herpes Treatment Industry Opportunities and Challenges Table 28. Herpes Treatment Industry Restraints Table 29. Global Herpes Treatment Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Herpes Treatment Revenue Market Share by Company (2021-2026) Table 31. Global Herpes Treatment Sales by Company (2021-2026) & (k units) Table 32. Global Herpes Treatment Sales Share by Company (2021-2026) Table 33. Global Herpes Treatment Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Herpes Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Herpes Treatment Major Company Production Sites and Headquarters Table 36. Global Herpes Treatment Company, Product Type & Application Table 37. Global Herpes Treatment Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Herpes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Herpes Treatment Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Herpes Treatment Sales by Region (2021-2026) & (k units) Table 42. Global Herpes Treatment Sales Market Share in Volume by Region (2021-2026) Table 43. Global Herpes Treatment Sales by Region (2021-2026) & (US$ Million) Table 44. Global Herpes Treatment Sales Market Share in Value by Region (2021-2026) Table 45. Global Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Herpes Treatment Sales by Region (2027-2032) & (k units) Table 47. Global Herpes Treatment Sales Market Share in Volume by Region (2027-2032) Table 48. Global Herpes Treatment Sales by Region (2027-2032) & (US$ Million) Table 49. Global Herpes Treatment Sales Market Share in Value by Region (2027-2032) Table 50. Global Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Herpes Treatment Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Herpes Treatment Sales by Application (2021-2026) & (k units) Table 53. Global Herpes Treatment Sales Market Share in Volume by Application (2021-2026) Table 54. Global Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 55. Global Herpes Treatment Sales Market Share in Value by Application (2021-2026) Table 56. Global Herpes Treatment Price by Application (2021-2026) & (US$/unit) Table 57. Global Herpes Treatment Sales by Application (2027-2032) & (k units) Table 58. Global Herpes Treatment Sales Market Share in Volume by Application (2027-2032) Table 59. Global Herpes Treatment Sales by Application (2027-2032) & (US$ Million) Table 60. Global Herpes Treatment Sales Market Share in Value by Application (2027-2032) Table 61. Global Herpes Treatment Price by Application (2027-2032) & (US$/unit) Table 62. North America Herpes Treatment Sales by Application (2021-2026) & (k units) Table 63. North America Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Herpes Treatment Sales by Application (2021-2026) & (k units) Table 65. Europe Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Herpes Treatment Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Herpes Treatment Sales by Application (2021-2026) & (k units) Table 69. Latin America Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Herpes Treatment Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Herpes Treatment Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Abbott Herpes Treatment Product Portfolio Table 76. Abbott Recent Development Table 77. Teva Pharmaceutical Industries Company Information Table 78. Teva Pharmaceutical Industries Business Overview Table 79. Teva Pharmaceutical Industries Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Industries Herpes Treatment Product Portfolio Table 81. Teva Pharmaceutical Industries Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Novartis Herpes Treatment Product Portfolio Table 86. Novartis Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Merck Herpes Treatment Product Portfolio Table 91. Merck Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Mylan Herpes Treatment Product Portfolio Table 96. Mylan Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Herpes Treatment Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Vical Company Information Table 103. Vical Business Overview Table 104. Vical Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Vical Herpes Treatment Product Portfolio Table 106. Vical Recent Development Table 107. Gilead Company Information Table 108. Gilead Business Overview Table 109. Gilead Herpes Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Gilead Herpes Treatment Product Portfolio Table 111. Gilead Recent Development Table 112. North America Herpes Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America Herpes Treatment Sales by Country (2021-2026) & (k units) Table 114. North America Herpes Treatment Sales Market Share by Country (2021-2026) Table 115. North America Herpes Treatment Sales Forecast by Country (2027-2032) & (k units) Table 116. North America Herpes Treatment Sales Market Share Forecast by Country (2027-2032) Table 117. North America Herpes Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Herpes Treatment Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Herpes Treatment Market Share by Country (2021-2026) Table 120. North America Herpes Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Herpes Treatment Market Share Forecast by Country (2027-2032) Table 122. Europe Herpes Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe Herpes Treatment Sales by Country (2021-2026) & (k units) Table 124. Europe Herpes Treatment Sales Market Share by Country (2021-2026) Table 125. Europe Herpes Treatment Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe Herpes Treatment Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Herpes Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Herpes Treatment Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Herpes Treatment Market Share by Country (2021-2026) Table 130. Europe Herpes Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Herpes Treatment Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Herpes Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Herpes Treatment Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific Herpes Treatment Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Herpes Treatment Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific Herpes Treatment Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Herpes Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Herpes Treatment Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Herpes Treatment Market Share by Country (2021-2026) Table 140. Asia-Pacific Herpes Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Herpes Treatment Market Share Forecast by Country (2027-2032) Table 142. Latin America Herpes Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America Herpes Treatment Sales by Country (2021-2026) & (k units) Table 144. Latin America Herpes Treatment Sales Market Share by Country (2021-2026) Table 145. Latin America Herpes Treatment Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America Herpes Treatment Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Herpes Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Herpes Treatment Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Herpes Treatment Market Share by Country (2021-2026) Table 150. Latin America Herpes Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Herpes Treatment Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Herpes Treatment Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Herpes Treatment Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Herpes Treatment Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Herpes Treatment Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa Herpes Treatment Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Herpes Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Herpes Treatment Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Herpes Treatment Market Share by Country (2021-2026) Table 160. Middle East and Africa Herpes Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Herpes Treatment Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Herpes Treatment Distributors List Table 165. Herpes Treatment Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Herpes Treatment Image Figure 2. Global Herpes Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Herpes Treatment Sales (2021-2032) & (k units) Figure 5. Famciclovir Image Figure 6. Global Famciclovir Sales YoY Growth (2021-2032) & (k units) Figure 7. Valacyclovir Image Figure 8. Global Valacyclovir Sales YoY Growth (2021-2032) & (k units) Figure 9. Acyclovir Image Figure 10. Global Acyclovir Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Herpes Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Herpes Treatment Market Share by Type 2025 VS 2032 Figure 13. North America Herpes Treatment Sales Market Share in Volume by Type in 2025 Figure 14. North America Herpes Treatment Sales Market Share in Value by Type in 2025 Figure 15. Europe Herpes Treatment Sales Market Share in Volume by Type in 2025 Figure 16. Europe Herpes Treatment Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Herpes Treatment Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Herpes Treatment Sales Market Share in Value by Type in 2025 Figure 19. Latin America Herpes Treatment Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Herpes Treatment Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Herpes Treatment Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Herpes Treatment Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Herpes Treatment Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospital Pharmacies Image Figure 28. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Drug Stores Image Figure 32. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Herpes Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Herpes Treatment Market Share by Application 2025 VS 2032 Figure 35. North America Herpes Treatment Sales Market Share in Volume by Application in 2025 Figure 36. North America Herpes Treatment Sales Market Share in Value by Application in 2025 Figure 37. Europe Herpes Treatment Sales Market Share in Volume by Application in 2025 Figure 38. Europe Herpes Treatment Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Herpes Treatment Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Herpes Treatment Sales Market Share in Value by Application in 2025 Figure 41. Latin America Herpes Treatment Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Herpes Treatment Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Herpes Treatment Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Herpes Treatment Sales Market Share in Value by Application in 2025 Figure 45. North America Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Herpes Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Herpes Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Herpes Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Herpes Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Herpes Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Herpes Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Herpes Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Herpes Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Herpes Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Herpes Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Herpes Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Herpes Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Herpes Treatment Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Herpes Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Herpes Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Herpes Treatment Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Herpes Treatment Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Famciclovir
  • Valacyclovir
  • Acyclovir
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries
  • Novartis
  • Merck
  • Mylan
  • GlaxoSmithKline
  • Vical
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Herpes Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Herpes Treatment Market by Type
  6. 1.3.1 Famciclovir
  7. 1.3.2 Valacyclovir
  8. 1.3.3 Acyclovir
  9. 1.4 Global Herpes Treatment Market Size by Type
  10. 1.4.1 Global Herpes Treatment Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Herpes Treatment Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Herpes Treatment Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Herpes Treatment Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Herpes Treatment Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Herpes Treatment Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Herpes Treatment Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Herpes Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Herpes Treatment Industry Trends
  2. 2.2 Herpes Treatment Industry Drivers
  3. 2.3 Herpes Treatment Industry Opportunities and Challenges
  4. 2.4 Herpes Treatment Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Herpes Treatment Revenue (2021-2026)
  2. 3.2 Global Top Players by Herpes Treatment Sales (2021-2026)
  3. 3.3 Global Top Players by Herpes Treatment Price (2021-2026)
  4. 3.4 Global Herpes Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Treatment Major Company Production Sites & Headquarters
  6. 3.6 Global Herpes Treatment Company, Product Type & Application
  7. 3.7 Global Herpes Treatment Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herpes Treatment Tier 1, Tier 2, and Tier 3
4 Herpes Treatment Regional Status and Outlook
  1. 4.1 Global Herpes Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Herpes Treatment Historic Market Size by Region
  3. 4.2.1 Global Herpes Treatment Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Herpes Treatment Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Herpes Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Herpes Treatment Forecasted Market Size by Region
  7. 4.3.1 Global Herpes Treatment Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Herpes Treatment Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Herpes Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Herpes Treatment by Application
  1. 5.1 Herpes Treatment Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Drug Stores
  6. 5.2 Global Herpes Treatment Market Size by Application
  7. 5.2.1 Global Herpes Treatment Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Herpes Treatment Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Herpes Treatment Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Herpes Treatment Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Herpes Treatment Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Herpes Treatment Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Herpes Treatment Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Herpes Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Herpes Treatment Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Teva Pharmaceutical Industries
  8. 6.2.1 Teva Pharmaceutical Industries Company Information
  9. 6.2.2 Teva Pharmaceutical Industries Business Overview
  10. 6.2.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Industries Herpes Treatment Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Herpes Treatment Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Herpes Treatment Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Herpes Treatment Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Herpes Treatment Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Vical
  38. 6.7.1 Vical Company Information
  39. 6.7.2 Vical Business Overview
  40. 6.7.3 Vical Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vical Herpes Treatment Product Portfolio
  42. 6.7.5 Vical Recent Developments
  43. 6.8 Gilead
  44. 6.8.1 Gilead Company Information
  45. 6.8.2 Gilead Business Overview
  46. 6.8.3 Gilead Herpes Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Gilead Herpes Treatment Product Portfolio
  48. 6.8.5 Gilead Recent Developments
7 North America by Country
  1. 7.1 North America Herpes Treatment Sales by Country
  2. 7.1.1 North America Herpes Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Herpes Treatment Sales by Country (2021-2026)
  4. 7.1.3 North America Herpes Treatment Sales Forecast by Country (2027-2032)
  5. 7.2 North America Herpes Treatment Market Size by Country
  6. 7.2.1 North America Herpes Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Herpes Treatment Market Size by Country (2021-2026)
  8. 7.2.3 North America Herpes Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Herpes Treatment Sales by Country
  2. 8.1.1 Europe Herpes Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Herpes Treatment Sales by Country (2021-2026)
  4. 8.1.3 Europe Herpes Treatment Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Herpes Treatment Market Size by Country
  6. 8.2.1 Europe Herpes Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Herpes Treatment Market Size by Country (2021-2026)
  8. 8.2.3 Europe Herpes Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Herpes Treatment Sales by Country
  2. 9.1.1 Asia-Pacific Herpes Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Herpes Treatment Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Herpes Treatment Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Herpes Treatment Market Size by Country
  6. 9.2.1 Asia-Pacific Herpes Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Herpes Treatment Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Herpes Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Herpes Treatment Sales by Country
  2. 10.1.1 South America Herpes Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Herpes Treatment Sales by Country (2021-2026)
  4. 10.1.3 South America Herpes Treatment Sales Forecast by Country (2027-2032)
  5. 10.2 South America Herpes Treatment Market Size by Country
  6. 10.2.1 South America Herpes Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Herpes Treatment Market Size by Country (2021-2026)
  8. 10.2.3 South America Herpes Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Herpes Treatment Sales by Country
  2. 11.1.1 Middle East and Africa Herpes Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Herpes Treatment Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Herpes Treatment Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Herpes Treatment Market Size by Country
  6. 11.2.1 Middle East and Africa Herpes Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Herpes Treatment Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Herpes Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Herpes Treatment Value Chain Analysis
  2. 12.1.1 Herpes Treatment Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Herpes Treatment Production Mode & Process
  7. 12.2 Herpes Treatment Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Herpes Treatment Distributors
  10. 12.2.3 Herpes Treatment Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst